Migraine in the triptan era: Progresses achieved, lessons learned and future developments

Marcelo E. Bigal, Abouch V. Krymchantowski, Tony Ho

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


Triptans, serotonin 5-HT1B/1D receptor agonists, more than revolutionizing the treatment of migraine, stimulated also ground breaking research that provided insights into the anatomy, physiology, and molecular pharmacology of migraine. This knowledge, in turn, is stimulating research on new mechanisms of action for the treatment of migraine. Accordingly, it is opportune to critically review the main advances in migraine science that happened in the triptan era. Herein we first review and conceptualize some of the progresses achieved in migraine science during the triptan era. We then review the class of the triptans - mechanism of action and clinical evidence. We close by briefly discussing the class of CGRP receptor antagonists, which is currently being developed for the acute treatment of migraine.

Original languageEnglish (US)
Pages (from-to)559-569
Number of pages11
JournalArquivos de Neuro-Psiquiatria
Issue number2 B
StatePublished - Jun 2009
Externally publishedYes


  • CGRP antagonists
  • Emerging drugs
  • Migraine
  • Triptans

ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry


Dive into the research topics of 'Migraine in the triptan era: Progresses achieved, lessons learned and future developments'. Together they form a unique fingerprint.

Cite this